In the BioHarmony Drug Report Database
Trovafloxacin
Trovan (trovafloxacin) is a small molecule pharmaceutical. Trovafloxacin was first approved as Trovan on 1997-12-18. It is used to treat bacterial pneumonia, bacteroides infections, bronchitis, chlamydia infections, and escherichia coli infections amongst others in the USA.
Trade Name
|
Trovan |
|---|---|
Common Name
|
trovafloxacin |
ChEMBL ID
|
CHEMBL428 |
Indication
|
bacterial pneumonia, bacteroides infections, bronchitis, chlamydia infections, escherichia coli infections, gonorrhea, haemophilus infections, klebsiella infections, pseudomonas infections, sinusitis, staphylococcal infections, streptococcal infections, urethritis |
Drug Class
|
Antibacterials (quinolone derivatives) |
Image (chem structure or protein)